✦ LIBER ✦

Cell-mediated immune response in head and neck cancer patients

✍ Scribed by Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 381 KB
Volume: 8
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930080405

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts.

DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with more than one primitive tumor, and in patients after radiation.

Candidine reactivity was impaired in bigger primitive tumors, positive nodes, and advanced stages, as well as in postradiation patients.

Blastic transformation was significantly worse in patients over 70 years and tended to be lower in patients with more than one primitive tumor. Good blastic transformation was also lowered in postradiation patients.

📜 SIMILAR VOLUMES

Circulating immune complexes and chemoth

Circulating immune complexes and chemotherapy response in patients with head and neck cancer

✍ Beverly A. Blazar; Dr. Marvin P. Fried; Marshall Strome; John R. Clark; Patricia 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

An assay which could prospectively predict a response to chemotherapy prior to instituting therapy would be beneficial, especially for nonresponders. We evaluated at random a total of 50 patients with previously untreated stage 111 and IV head and neck squamous cell carcinoma for T-cell subsets and

Impaired cell-mediated immunity in patie

Impaired cell-mediated immunity in patients with cancer

✍ Dr. Joseph A. Buda; N. Suciu-Foca; Eric Blomain; Susan McManus; Keith Reemtsma 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Immune response in patients with cancer

✍ Sidney Leskowitz; Lucio Phillipino; Grace Hendrick; John B. Graham 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

O ~I defcitse against cancer probably ex-H ists to a significant degree. T h e development of clinical cancer may indicate an impaired resistance, one manifestation of which could be an altered antibody response to standard antigens. T h e ability of patients with chronic leukemia to form antibodie

Genomic instability in head and neck can

Genomic instability in head and neck cancer patients

✍ Paul L. Friedlander 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: In the normal host, there are a variety of cellular systems that ensure the accurate replication and repair of dna. recent evidence suggests that there are individual variations in the ability to preserve the genome. certain individuals have defects in these checkpoints and have an i

Head and neck cancer in young black pati

Head and neck cancer in young black patients

✍ Nahum, Alan M. 📂 Article 📅 1983 🏛 Wiley (John Wiley & Sons) ⚖ 44 KB 👁 2 views

In this issue, G. J. Slotman and his colleagues review 1,066 patients with cancer of the head and neck (Head and Neck Cancer in a Young Age Group: High Incidence in Black Patients). They identify a significantly increased proportion of young black patients in the total group of black head and neck c

Regulatory T cells: What role do they pl

Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?

✍ Osama Alhamarneh; Shoba M. P. Amarnath; Nicholas D. Stafford; John Greenman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

## Abstract Advances in the treatment modalities for head and neck squamous cell carcinoma (HNSCC) over the last 20 years involving surgery, radiotherapy, chemotherapy, and immunotherapy are not fully reflected in increases in the 5‐year survival rates, mainly due to locoregional recurrences and to